| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.003 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |